Enzalutamide (Xtandi) More Effective Than Bicalutamid in Prostate Cancer Trial

Enzalutamide (Xtandi) More Effective Than Bicalutamid in Prostate Cancer Trial

The study enrolled patients with metastatic prostate cancer whose disease had progressed despite treatment with a luteinizing hormone-releasing hormone (LHRH) analogue or after surgical castration. The study's primary endpoint was progression-free …

(Visited 3 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.